Champions Oncology (CSBR) has announced a strategic collaboration with Turbine. This partnership is set to revolutionize biopharma drug discovery workflows by integrating Champions’ multi-omic dataset with Turbine’s virtual lab technology. By combining Champions’ comprehensively annotated, clinically relevant multi-omic datasets with Turbine’s virtual cell-based simulation platform and its capacity to generalize beyond training data, researchers can now conduct in silico experiments with exceptional speed and precision, covering perturbations they would otherwise be unable to investigate. This significant synergy minimizes reliance on traditional laboratory methods and enhances drug discovery initiatives, ranging from target identification to the generation of mechanistic insights, through the integration of highly translational multi-omics datasets.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSBR:
